William J. Febbo - 18 Apr 2023 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
CEO, Director
Signature
/s/ Marion Odence-Ford, by Power of Attorney
Issuer symbol
OPRX
Transactions as of
18 Apr 2023
Transactions value $
$0
Form type
4
Filing time
20 Apr 2023, 15:15:46
Previous filing
03 Apr 2023
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Restricted Stock Units Award $0 +86.7K $0.00 86.7K 18 Apr 2023 Common 86.7K Direct F1, F2
transaction OPRX Stock Option Award $0 +162K $0.00 162K 18 Apr 2023 Common 162K $14.42 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
F2 The restricted stock units vest in three equal annual installments beginning April 18, 2024, the first anniversary of the grant date.
F3 The stock option vests in three equal annual installments beginning April 18, 2024, the first anniversary of the grant date.